Genovis AB (publ.) (GENO) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.00x

Genovis AB (publ.) (GENO) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr15.90 Million (capex Skr15.90 Million ) from operating cash flow of Skr15.90 Million. See cash generation quality of Genovis AB (publ.) to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr15.90 Million
Capex + Investments

Operating Cash Flow

Skr15.90 Million
SEK

Capital Expenditures

Skr15.90 Million
SEK

Genovis AB (publ.) Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for Genovis AB (publ.) across 6 annual periods. For the full cash flow conversion analysis, see GENO operating cash flow.

Annual Cash Flow Reinvestment Rate for Genovis AB (publ.) (2019–2025)

Year-by-year capital reinvestment analysis for Genovis AB (publ.). See financial agility of Genovis AB (publ.) to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2025 1.00x Skr32.02 Million Skr32.02 Million Skr32.02 Million ▲ +139.3%
2024 0.42x Skr15.51 Million Skr37.12 Million Skr1.09 Million ▼ -47.5%
2023 0.80x Skr53.94 Million Skr67.75 Million Skr12.81 Million ▲ +493.8%
2021 0.13x Skr6.16 Million Skr45.92 Million Skr4.49 Million ▼ -97.7%
2020 5.88x Skr22.10 Million Skr3.76 Million Skr20.43 Million ▲ +1032.5%
2019 0.52x Skr6.82 Million Skr13.13 Million Skr5.15 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow